Can the flow of medicines be improved? Fundamental pharmacokinetic and...
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacologicalprinciples toward improving Phase II survival
View ArticleSteve Street,Vice President and General Manager of Early Development at...
Steve Street,Vice President and General Manager of Early Development at Covance, talks about Phase I & IIa 2012.
View ArticleInterview with Neil Smith, Director Regulatory Affairs, Chorus,Lilly Research...
Interview with Neil Smith, Director Regulatory Affairs, Chorus,Lilly Research Laboratories.
View ArticleLawrence Lesko, Director of the Office of Clinical Pharmacology in the Center...
Lawrence Lesko, Director of the Office of Clinical Pharmacology in the Center for Drug Evaluation and Research, FDA; currently Professor and Director, Center for Pharmacometircs and Systems...
View ArticleSteffen Ernst, Head Translational Patient Safety, AstraZeneca
Steffen Ernst, Head Translational Patient Safety, AstraZeneca
View ArticleTHE R&D COST OF A NEW MEDICINE_ Jorge Mestre-Ferrandiz, Jon Sussex and Adrian...
THE R&D COST OF A NEW MEDICINE_ Jorge Mestre-Ferrandiz, Jon Sussex and Adrian Towse_ Office of Health Economics
View ArticleTop 5 blog entries for early phase clinical trials...
Top 5 blog entries for early phase clinical trials...
View ArticleAlan Houston, Director, Three Bridges Consultant Ltd., UK
Alan Houston, Director, Three Bridges Consultant Ltd., UK
View ArticleRecommended Reading for Phase I & IIa Clinical Trials.
Recommended Reading for Phase I & IIa Clinical Trials.
View Article
More Pages to Explore .....